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Abstract  
Glycogen, a hyperbranched glucose polymer, is the blood-sugar reservoir in animals. Liver 
glycogen comprises small β particles, which can join together as large composite α particles. 
It had been shown that the binding between β in α particles in the liver of diabetic mice is 
more fragile than in healthy mice. This could be linked to the loss of blood-sugar control 
characteristic of diabetes if the rate per monomer unit of the enzymatic degradation to glucose 
of α particles were significantly slower than that of β particles. This is tested here by 
examining the in vitro time evolution of the molecular size distribution of glycogen from the 
livers of healthy rats and diabetic mice, containing distinct components of both α and β 
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particles; this treatment is analogous to the “competitive growth” method used to explore 
mechanisms in emulsion polymerization. Simulations for the time evolution of the molecular 
size distribution were also performed. It is found that the degradation rate per monomer unit is 
indeed faster for the smaller particles, supporting the hypothesis of a causal link between 
chemical fragility of glycogen from diabetic liver with poor control of blood-sugar release.
 Comparison between simulations and experiment indicate that α and β particles have 
significant structural differences.
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1. Introduction
 
Glycogen is a highly branched polymer of glucose that comprises two types of particles: small 
β particles (~20 nm in diameter), which can form large α particles (up to 300 nm in diameter)
 which have a cauliflower-like appearance under transmission electron microscopy [1-3].
 
Glycogen predominantly exists in brain, muscle [4], heart [5] and liver, functioning as a 
buffer to release or store glucose as appropriate.
  
We have shown previously that liver glycogen in db/db mice (an animal model of type 2 
diabetes) has similar amounts of α particles to healthy liver glycogen. However, the α 
particles from diabetic mice are much more fragile [6], e.g. to solvents which break hydrogen 
bonds, than those from healthy mice. They would thus be more readily broken down into β 
particles [7] in the liver. This phenomenon could be related to the hyperglycemia (high blood 
glucose, loss of blood-sugar control) that is characteristic of diabetes if the degradation 
process of β particles to glucose were to be at a faster rate than that of α particles.
 
This study investigates the relative rates of the degradation processes of α and β particles from 
the livers of healthy rats, healthy mice and diabetic db/db mice, by examining the time 
evolution of glycogen molecular size distribution during in vitro enzymatic degradation.  
Glycogen phosphorylase, which catalyzes the breakdown of glycogen by cleaving (1⟶4)-α 
glycosidic bonds [8, 9], was used to imitate glycogenolysis in vitro. Size-exclusion 
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chromatography (SEC, also termed gel-permeation chromatography, GPC), which separates 
fully dissolved and dispersed polymer molecules by size (the hydrodynamic radius Rh), was 
used to examine the molecular size distributions of glycogen at different degradation times 
[10]. Studying the time evolution of bimodal size distributions to make mechanistic 
inferences is analogous to the “competitive growth” experiments used to develop mechanistic 
understanding of growth processes in emulsion polymerization [11]. 
 
2. Experimental 
2.1.  Animals 
Male Wistar rats (8 weeks), male C57 mice (12 weeks) and male C57BL/6j-db/db mice (12 
weeks) were used. Rats and C57 mice were purchased from Hubei Provincial Food and Drug 
Safety Center. C57BL/6j db/db mice were purchased from the Model Animal Research 
Center of Nanjing University. Animals were housed in standard cages, with the temperature 
controlled at 22 ± 1°C. A 12 h dark/light cycle was used, with lights on at 7 am and off at 7 
pm. Animals had ad libitum access to standard chow (6% kcal from fat, 14.3 MJ kg–1, Hubei 
Provincial Center for Disease Control and Prevention) and water. Animals were anaesthetized 
with sodium pentobarbitone (150 mg kg–1, i.p.), with their livers rapidly excised and snap-
frozen in liquid nitrogen. Samples were stored at –80 °C. All animal experiments were 
approved by the Huazhong University of Science and Technology Tongji Medical College 
Animal Care and Ethics Committee. 
2.2.  Glycogen extraction and purification 
Glycogen extraction was carried out following our published method with some modifications 
[12]. Liver glycogen was homogenized, and a stepwise sucrose gradient (37.5% and 75% in 
deionized water) method was used to remove non-glycogen components. Glycogen was 
further purified by ethanol precipitation, and then dissolved in 1 mL of deionized water and 
lyophilized (VirTis BTP-9EL freeze-dryer). 
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2.3.  Glycogen degradation 
Glycogen degradation was analyzed as described elsewhere [12]. This used a buffer solution 
obtained by mixing 500 mM potassium phosphate (100 mL), 300 mM magnesium chloride (5 
mL) and 100 mM EDTA (1 mL) (adjusted to pH 6.8). The digestion buffer was obtained by 
mixing this solution (1.5 mL) with deionized water (10 mL), NADP (6.5 mM) and 0.1% (w/v) 
α-D glucose 1,6-disphosphate. 2 mg of liver glycogen was dissolved in 1.2 mL digestion 
buffer and then incubated at 80 °C with agitation at 350 rpm for 4 h. The following reagents 
(Sigma) were added in this mixture: glycogen phosphorylase (40 μL, 1 mg mL–1), 
phosphoglucomutase (24 μL, 10 U mL–1), glucose-6-phosphate dehydrogenase (24 μL, 10 U 
mL
–1
) and 5′AMP (2 μL, 100 mM). Samples were collected after 0, 20 and 60 min, and 
absolute ethanol added (4 times) to terminate the reaction. These times were chosen so as to 
cover the range from the time the degradative enzyme was added to when the glycogen was 
almost completely degraded. Digested glycogen was collected after centrifugation at 4000 g 
for 10 min, and was re-dissolved in 0.3 mL of deionized water and lyophilized (freeze-dryer; 
VirTis, BTP-9EL) for SEC analysis. 
2.4.  Size-chromatography (SEC) of glycogen 
The SEC weight distribution of glycogen, w(log Rh), which gives the distribution of the 
weight of particles as a function of log Rh, was analyzed using an Agilent 1260 Infinity SEC 
system (Agilent, Santa Clara, CA, USA) with a refractive index detector (RID, Optilab UT-
rEX, Wyatt, Santa Barbara, CA, USA) following a previously reported method [6]. Water 
containing 50 mM ammonium nitrate/0.02% sodium azide was used as eluent, and separation 
of molecules by size used a SUPREMA pre-column, 1000 and 10,000 columns (Polymer 
Standard Service, Mainz, Germany). 
3. Simulations 
Two approaches were used to simulate the time evolution of the molecular size distribution 
under enzymatic degradation. Both were based on analogous methods used in emulsion 
polymerization. The first approach was through the partial differential equation involving a 
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single model describing this evolution, analogous to the full description of the particle size 
distribution in emulsion polymerization during particle formation and growth [13], and is an 
extension of that used previously for glycogen degradation under acidic conditions [14]. The 
second approach treated the α- and β-particle populations as separate entitles, analogous to the 
description used for competitive growth in emulsion polymerization [11]. 
The partial differential equation describing the time evolution of the molecular size evolution 
[14] is: 
    
∂N(R,t)
∂t
 = 
∂
∂V
 (K N)  (1) 
where N(R,t) is the number distribution of molecules of radius R = Rh, V = 4/3 π R3 is the 
corresponding volume, and K is the rate coefficient for enzymatic degradation. In the 
extension of the form of this equation implemented here, it is assumed that  
 K = kRn     (2) 
where n = 3 corresponds to uniform degradation throughout the particle (as implemented 
previously [14]), n = 2 to degradation on the surface, and n = 1 to diffusion-controlled 
degradation (e.g. eq 6 in [11]). The number distribution is converted to the SEC weight 
distribution w(log Rh), and specific inclusion of the radius dependence of K gives: 
 
∂w(logR,t)
∂t
 = 
1
4 π
[k(n – 6) Rn–3w(logR,t)  + kRn – 2 
∂w(logR,t)
∂R
]     (3) 
This equation is solved numerically by finite difference, as set out in the Supporting 
Information.  
This model implicitly assumes that all glycogen particle sizes have the same type of structure: 
there is only a single population of particles. However, as stated, α particles are agglomerates 
of β particles, and so one expects qualitative structural differences between isolated β 
particles and their aggregated form as α particles; this is distinct from phytoglycogen, where 
there is evidence [14] that these particles have a uniform type of structure at all sizes. If one 
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treats α and β particles as structurally different entities, then the system would be described by 
two dependent variables, the distributions for α and β particles as separate w(log Rh). A much 
simpler approach is to treat the populations as kinetically separate, analogous to what has 
been done for competitive growth in emulsion polymerization [11], as set out in the 
Supporting Information. 
4. Results and Discussion 
The time evolutions of the molecular size distributions of liver glycogen from healthy rats, 
diabetic and healthy mice are shown in Figure 1; the reproducibility of the data is given in the 
Supporting Information. Two peaks are observed, at Rh ~ 40 and 20 nm, which are the 
glycogen α and β particles, respectively. The healthy rat-liver glycogen used in this study 
comprises predominantly β particles, the healthy mice-liver glycogen involved in this study 
contains more α than β particles, and the diabetic mouse-liver glycogen has commensurate 
components of both α and β particles. The relative amounts of α and β particles depends on 
the time of day in a given animal [12]; the different relative amounts of particles in the 
different animals arises because the three glycogen samples are from rats sacrificed at 8 am 
(Figure 1A ), and from healthy mice sacrificed at 10 am (Figure 1C) and diabetic mice 
sacrificed at 4 pm (Figure 1B).  
Figure 1 shows that the amount of β particles decreased rapidly over time for healthy rat-liver 
glycogen (Figure 1A), whereas the decrease in α particles only becomes obvious after 20 min, 
and a significant amount of α particles remains after 60 min degradation. The same effect was 
seen for diabetic mice-liver glycogen (Figure 1B) and healthy mice-liver glycogen (Figure 
1C). This shows that the enzymatic degradation rate of β particles is much quicker than that of 
α particles for both healthy and diabetic glycogen derived from rats and mice.  
The enzymatic degradation rate of glycogen may be affected by many factors. The nature of 
the link between β into α particles is not yet known (although it may involve a protein) [15]. 
The ratio of surface area to volume could play a major role in the enzymatic degradation rate. 
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β particles have a greater surface/volume ratio (per glucose monomer unit), which would 
increase the availability of glucose monomer units (per monomer unit) to degradation 
enzymes, compared to α particles [10]. These data indicate that the size of glycogen 
molecules has a major influence on their enzymatic degradation rate: it is clear from Fig. 1A 
and Fig. 1C that β particles degrade much more quickly than α particles. 
Rats and mice follow a diurnal eating cycle, with the first meal in a 24-h period taken early in 
the evening, and the last meal early in the morning. During the fasting stage (i.e. well after the 
last meal), glycogen phosphorylase is released and/or activated, and this enzyme will quickly 
degrade β particles. The fragility of α particles in diabetes means that the α particles would be 
easily degraded to β particles, which then would degrade much more rapidly (per glucose 
monomer unit) than would be the case for a healthy animal, where the α particles are not 
fragile.  
More information about this was obtained using the simulation of eqs 1 and 2 to see how well 
the data could be fitted. Some results are shown in Fig. 2, using as the zero-time distribution 
the observed w(log Rh) for healthy rats and diabetic mice of Fig. 1.  
An apparent inconsistency in the simulation results is that one expects the distribution to 
move towards smaller Rh with degradation, but this is not apparent from the data in terms of 
w(log Rh). In actuality, it is the number distribution that should show this behaviour, and on 
presenting the same simulation data as log N(log Rh), as shown in the Supporting Information, 
this expected behaviour is indeed seen.  
The best fit was obtained with n = 1, and k = 0.75 and 0.45 nm–2 min–1 for healthy rats and 
diabetic mice, respectively. Superficially, it appears that the model is able to reproduce the 
data quite well. However, this is not quite the case, because closer inspection shows some a 
subtle feature which is not reproduced by the simulation. This is the fact that the data for 
healthy rats at t = 20 min shows two distinct peaks (corresponding to β and α particles) of 
essentially the same height. The simulations however for t = 20 min show that the smaller size 
(β) peak is significantly higher than that for the larger (α) particles, and at a later time (the 
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black lines in the simulation) when the two simulated peaks are the same height, they are 
merging into each other and are not as distinct as in experiment. Bearing in mind that 
experimental SEC band broadening means that the true experimental peaks are even more 
distinct, these apparently small differences are in fact significant. There is no such qualitative 
difference between the simulated and observed distributions for the diabetic livers. 
The conclusion to be drawn from this is that the small but qualitatively significant difference 
suggests that there are significant structural differences between α and β particles. This is 
indeed consistent with our previous inferences from a different type of study of glycogen 
degradation [14].
 
As stated, this model implicitly assumes that all particles have the same type of structure, and 
an alternative model is to treat α and β particles as separate entities. A simple two-state 
treatment, as detailed in the Supporting information, and assuming each population obeys 
first-order kinetics, (concentration) ∝ exp[–k(Rh)] with t k = ARhn, gives n = 1.4 ± 0.2. 
Although simplistic, this two-population treatment gives the value of the exponent n which is 
consistent with that of n = 1 found to give the best agreement of the full single-population 
simulation.
 
5. Conclusions
 
Our data imply a more rapid release from β particles under enzymatic degradation following 
the breakup of fragile diabetic α particles, an effect that may well be a significant contribution 
to the high postprandial blood glucose (uncontrolled glucose release) characteristic of 
diabetes. Simulation of the data support the inference that there are some structural 
differences between α and β particles, as expected for liver glycogen where the α particles are 
composites of many β particles.
  
The relation of the present results to in vivo systems is an important one, and to investigate 
this requires an examination of the dependence of time after last meal prior to sacrifice of the 
molecular size distribution of glycogen in healthy and diabetic animals. This work is currently 
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underway, analogous to our earlier study for healthy animals [12], extended to db/db mice and 
with the use of improved SEC techniques [16].   
This new understanding of a probable link between diabetes and glycogen macromolecular 
structure has the potential to provide guidance to develop new drug targets to prevent, and/or 
to alleviate the symptoms of, diabetes. 
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Figure captions 
Figure 1. SEC weight distributions, w(log R
h
), of liver glycogen from healthy rats (A), 
diabetic mice (B) and healthy mice (C) as a function of hydrodynamic radius, Rh, at different 
times as indicated. Three repeats were performed (see Supporting Inofrmation) and the data in 
this figure are representative.  
Figure 2. Simulated time evolution of SEC weight distributions for healthy rats (A) and 
diabetic mice (B), from the model of eqs 1 and 2, at t = 0 (blue dots), 20 (red dashes) and 60 
(green unbroken line) min. The t = 0 values are the experimental initial distributions of Fig. 1, 
and the best-fit simulation parameter values are given in the text. Black lines are for 
intermediate and later times. 
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Highlights 
 Glycogen, a complex branched glucose polymer, helps maintain blood-sugar level 
 Small β particles bind into large α particles; the binding is fragile in diabetes 
 We study the time evolution of molecular size distribution with degradative enzyme 
 This shows small particles degrade more rapidly to glucose than large ones 
 This is consistent with uncontrolled blood sugar levels in diabetes 
 
 
